HYDI 10KSB/A 06-30-05
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON
D.C. 20549
FORM
10-KSB/A
ANNUAL
REPORT UNDER SECTION 13 OR 15 (d)
OF
THE
SECURITIES EXCHANGE ACT OF 1934
For
the
fiscal year ended June 30, 2005
Commission
File Number 0-10683
HYDROMER,
INC.
|
(Exact
name of registrant as specified in its charter)
|
New
Jersey
|
22-2303576
|
(State
of incorporation)
|
(I.R.S.
Employer
|
Identification
No.)
|
Identification
No.)
|
|
|
35
Industrial Pkwy, Branchburg, New Jersey
|
08876-3424
|
(Address
of principal executive offices) (Zip Code)
|
|
|
|
Registrant's
telephone number, including area code:
|
(908)
722-5000
|
|
|
Securities
registered pursuant to Section 12 (b) of the Act: None
|
|
|
|
Securities
registered pursuant to Section 12 (g) of the Act:
|
|
|
|
Common
Stock Without Par Value
|
(Title
of class)
|
|
|
Check
whether the issuer (1) has filed all reports required to be filed by Section
13
or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such
report(s) and (2) has been subject to such filing requirements for the past
90
days. Yes
x
No
¨
Check
if
there is no disclosure of delinquent filers in response to Item 405 of
Regulation S-B is not contained in this form, and no disclosure will be
contained, to the best of registrant's knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this Form 10-KSB
or any amendment to this Form 10-KSB x
The
aggregate market value of the voting stock held by non-affiliates of the
Registrant at September 1, 2005 was approximately $5,086,336.
The
number of shares of Registrant's Common Stock outstanding on September 1, 2005
was 4,623,942.
Portions
of the Audited Financials Statements for the year ended June 30, 2005 are
incorporated by reference in Part II of this report. Portions of the Proxy
Statement of Registrant dated September 15, 2005 are incorporated by reference
in Part III of this report.
Explanation
for filing of Amendment:
Inclusion
of Item # 8a, which was inadvertently omitted, to properly reflect the required
Item 307 information of Regulation S-B.
Item
# 8a. DISCLOSURE
CONTROLS AND PROCEDURES
As
of the
period covered by this report, the Company carried out an evaluation, under
the
supervision and with the participation of our management, including the Chief
Executive Officer and President and the Chief Financial Officer, of the
effectiveness of the design and operation of the disclosure controls and
procedures.
Based
upon this evaluation, our Chief Executive Officer and Chief Financial Officer
concluded that, our disclosure controls and procedures were effective and that
there were no changes to our Company’s internal control over financial reporting
that have materially affected, or is reasonably likely to materially affect
the
Company’s internal control over financial reporting during the period covered by
the Company’s annual report.
Exhibits
POWER
OF ATTORNEY
The
Company and each person whose signature appears below hereby appoint Manfred
F.
Dyck and Robert Y. Lee as attorneys-in-fact with full power of substitution,
severally,
to
execute in the name and on behalf of the registrant and each such person,
individually and in each capacity stated below, one or more amendments to the
annual report
which
amendments may make such changes in the report as the attorney-in-fact acting
deems appropriate and to file any such amendment to the report with the
Securities and
Exchange
Commission.
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf
by
the
undersigned
thereunto duly authorized.
HYDROMER,
INC.
|
|
|
|
|
|
/s/
Manfred F. Dyck
|
President,
Principal Executive Officer,
|
May
19, 2006
|
Manfred
F. Dyck
|
Chairman
of the Board of Directors
|
|
|
|
|
/s/
Robert Y. Lee
|
Chief
Accounting Officer
|
May
19, 2006
|
Robert
Y. Lee
|
|
|
|
|
|
Pursuant
to the requirements of the Securities and Exchange Act of 1934, this
report has been signed below by the following persons on behalf of
the
registrant and in the capacities
and
on the dates indicated:
|
|
|
|
/s/
Manfred F. Dyck
|
President,
Principal Executive Officer,
|
September
12, 2005
|
Manfred
F. Dyck
|
Chairman
of the Board of Directors
|
|
|
|
|
/s/
Robert H. Bea
|
Director
|
September
9, 2005
|
Robert
H. Bea
|
|
|
|
|
|
/s/
Maxwell Borow
|
Director
|
September
13, 2004
|
Maxwell
Borow, MD
|
|
|
|
|
|
/s/
Ursula M. Dyck
|
Director
|
September
13, 2005
|
Ursula
M. Dyck
|
|
|
|
|
|
/s/
Dieter Heinemann
|
Director
|
September
12, 2005
|
Dieter
Heinemann
|
|
|
|
|
|
/s/
Klaus J.H. Meckeler
|
Director
|
September
15, 2004
|
Klaus
J.H. Meckeler, MD
|
|
|
|
|
|
/s/
Frederick L. Perl
|
Director
|
September
12, 2005
|
Frederick
L. Perl, MD
|
|
|
|
|
|
/s/
Michael F. Ryan
|
Director
|
September
12, 2005
|
Michael
F. Ryan, PhD
|
|
|
|
|
|
|
|
|